Abapo, Randy O.
HRN: 25-69-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CEFTRIAXONE 1G (VIAL)
08/13/2024
08/20/2024
IV
2g
Q24
Fracture Closed Complete M3rd Humerus Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes